This fund invests in a portfolio of 20 international healthcare giants. They include such widely recognized names as Johnson & Johnson, Merck, Pfizer, and Bristol-Myers Squibb as well as some companies you may not be familiar with like Quest Diagnostics and Anthem.
Income Investor
One of the attractions of this ETF is the consistency of its distributions. They have been maintained at US$0.0583 per month since the fund was launched. Assuming that rate continues, the forward yield is 8.2%. -Gordon Pape
Sorry!
Only current subscribers of The Income Investor may view the details of this recommendation.
Interactive Performance Chart
HHL.U was first recommended here on July 2, 2018